|
RIOK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6304735339645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33146835171283E-14 |
| Normal-vs-Stage2 |
1.150300E-02 |
| Normal-vs-Stage3 |
1.54029999999139E-06 |
| Normal-vs-Stage4 |
9.759900E-04 |
| Stage1-vs-Stage2 |
8.236400E-01 |
| Stage1-vs-Stage3 |
2.381000E-01 |
| Stage1-vs-Stage4 |
6.393500E-02 |
| Stage2-vs-Stage3 |
7.285400E-01 |
| Stage2-vs-Stage4 |
4.409400E-01 |
| Stage3-vs-Stage4 |
4.573600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65145674912992E-12 |
| Normal-vs-AfricanAmerican |
3.163300E-03 |
| Normal-vs-Asian |
7.600200E-02 |
| Caucasian-vs-AfricanAmerican |
1.659640E-01 |
| Caucasian-vs-Asian |
5.310000E-01 |
| AfricanAmerican-vs-Asian |
2.100600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.1359031451077E-11 |
| Normal-vs-Female |
4.23172608066125E-12 |
| Male-vs-Female |
2.483000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.925650E-01 |
| Normal-vs-Age(41-60Yrs) |
8.36264391068653E-12 |
| Normal-vs-Age(61-80Yrs) |
2.38480002412444E-09 |
| Normal-vs-Age(81-100Yrs) |
3.583100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.523300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.659420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.031700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.671700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.325400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.929840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.275000E-03 |
| Normal-vs-Grade 2 |
1.75492953502498E-12 |
| Normal-vs-Grade 3 |
1.47790002458237E-10 |
| Normal-vs-Grade 4 |
2.567600E-01 |
| Grade 1-vs-Grade 2 |
9.730800E-01 |
| Grade 1-vs-Grade 3 |
5.126200E-01 |
| Grade 1-vs-Grade 4 |
1.840120E-02 |
| Grade 2-vs-Grade 3 |
8.145700E-02 |
| Grade 2-vs-Grade 4 |
2.14509999996171E-06 |
| Grade 3-vs-Grade 4 |
1.039690E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
5.424100E-02 |
| ccA subtype-vs-ccB subtype |
1.70141678523805E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.96349961132125E-10 |
| Normal-vs-N1 |
1.690420E-01 |
| N0-vs-N1 |
4.749800E-01 |
|
|
